• Cumulus Neuroscience

  Participated · Equity · May 2021

  Cumulus Neuroscience builds the NeuLogiq platform, which combines a novel dry-sensor EEG headset and tablet-based assessments to measure cognition, mood, and language across multiple domains. The headset received FDA 510(k) clearance in 2023 and is designed for use in clinic and at home, aiding data capture in conditions such as Alzheimer’s where testing can be difficult. The NeuLogiq Platform was developed with input from ten biopharma companies to provide more objective, multi-domain brain-function data than traditional pen-and-paper assessments. The company positions its tools to help biopharma establish baselines, demonstrate target engagement, and identify patient cohorts most likely to benefit from therapies. Cumulus says the funding will support marketing and the scaling of key hires including a Head of B2B Marketing and Sales Operations and a Vice President of Business Development. CEO Tina Sampath has framed the product as addressing a substantial unmet need in neuroscience clinical studies by delivering objective data to advance discovery and development. Cumulus Neuroscience develops AccelADx, an AI-enabled screening test that detects subtle changes in brain waves associated with memory recall to support earlier detection of Alzheimer's dementia. Its NeuLogiq™ platform includes an FDA-cleared and UKCA-marked dry-electrode EEG headset synchronized with tablet-based neuro-assessments for in-clinic or at-home use. The platform is designed to generate multi-domain digital biomarkers and support decentralized CNS clinical trials; it was developed with input from ten leading pharma companies. Cumulus plans to validate AccelADx in the Global Alzheimer's Platform Foundation (GAP) Bio-Hermes 2 Study, gaining regulatory-standard data to support submissions. The company positions AccelADx as complementary to protein biomarkers and scalable for broader clinical adoption. Cumulus is supported by specialized investors DDF/SV Health Investors, LifeArc and Future Fund. Cumulus Neuroscience, formerly BrainWaveBank, provides real-world clinical trial data and AI-powered insights via an integrated biomarker platform co-developed with pharmaceutical companies. The platform captures frequent, longitudinal brain activity measurements synchronized with mobile device-based assessments covering cognition, mood, language and sleep. Its home-usable EEG headset objectively probes neuronal integrity, network connectivity and compensatory brain strategies. Data are securely stored in the cloud and analysed with a machine-learning architecture to combine behavioural, physiological and functional signals. The company intends to use the new funding to accelerate the development of CNS therapies. Ronan Cunningham leads the company.

• EVRYTHNG

  Participated · Equity · Oct 2020

  EVRYTHNG offers the EVRYTHNG Product Cloud™, which digitizes products at scale and enables consumer brands to run their businesses with data-driven intelligence using product-generated data. The platform supports brands across apparel, beauty and personal care, home goods, and food and beverages. EVRYTHNG works with global customers including Ralph Lauren, PUMA, P&G, Moët Hennessy and Anheuser-Busch InBev. The company has launched strategic partnerships with Minet Technologies (Israel), The Results Group (Australia), Practical Methods (South Korea) and Hive (South Africa). Led by CEO and co-founder Niall Murphy, EVRYTHNG plans to use new funding to accelerate global growth, expand product capabilities for end-to-end supply chain traceability and visibility, and develop machine-learning applications for brand integrity while adding to its team. The company is based in London, UK and has raised a total of $60M to date. Evrythng provides an enterprise IoT platform that creates “intelligent software identities” for physical products using smart tags (QR codes), NFC, BLE, RFID or direct internet connections. The platform serves as the data layer for companies pursuing digital transformation and managing product digital identities. Its primary use cases are supply-chain tracking (location, authenticity, recalls), direct-to-consumer smart-packaging experiences and directly connected smart-home products. Over the past 12 months Evrythng has announced partnerships with global packaging firms including Avery Dennison RBIS, Crown Holdings and WestRock. The company was founded in 2011. Recently Evrythng closed a $24.8M Series B, and the new funding is intended to support additional partnerships, expansion of the team and further platform development. EVRYTHNG provides an Internet of Things smart products platform that connects consumer products to the Web and manages real-time data to drive applications. The company works with global consumer product brands including Diageo, Mondelez, Unilever, iHome, Avery Dennison, ThinFilm Electronics, Trueffect and Marvell. EVRYTHNG has offices in London, New York and San Francisco and is led by founder and CEO Niall Murphy. It raised $7.5M in the latest funding round and has raised $17.5M to date. Backers in the round included BHLP, Atomico, Dawn Capital, Cisco Systems, Samsung Ventures and others. The company said it will use the funds to expand the capabilities of its platform and operations and also announced hiring and advisory additions to support growth. Evrythng offers a software data-management layer that gives individual products intelligent online identities, connecting them to the Web without building hardware. The platform manages data flowing to, from and around connected objects and supports identifiers such as RFID tags and QR codes. The company focuses on three areas: customer engagement with products, smart supply chains, and connected products. Cisco has invested and will enable integration of Evrythng’s platform with Cisco’s IOX and CMX hardware technologies. Evrythng raised a $7M Series A to accelerate its mission to connect every individual product to the Web and to work with global manufacturers and retail brands. Some observers cited the opportunity as a potential $500 billion market as IoT adoption accelerates. Evrythng offers a platform that assigns "Active Digital Identities" to physical products, creating unique online profiles and a toolkit for developers and brands to build applications linked to those objects. The company positions smartphones as the key interface for consumers to "check in" to products and receive dynamic content and services. Its platform is described as secure and aimed at uses including personalised marketing, reduced POS and service costs, and anti‑counterfeit verification. Evrythng is running a closed beta developer program, is talking to other manufacturers of consumer goods, and is building a partnership program for marketing agencies. The startup announced drinks giant Diageo as its first partner. Founding team members include Niall Murphy and Andy Hobsbawm, joined by Swiss engineers Vlad Trifa and Dom Guinard; Murphy previously co‑founded The Cloud. The company is based in the UK and Switzerland and has received early financing to support its rollout.

No current team members are available.